SELECTIVE ANTAGONISM OF S2-SEROTONERGIC RECEPTORS RELIEVES BUT DOES NOT PREVENT COLD INDUCED VASOCONSTRICTION IN PRIMARY RAYNAUDS-PHENOMENON
- 1 April 1986
- journal article
- research article
- Vol. 13 (2) , 337-340
Abstract
In a double blind placebo crossover study, intravenous ketanserin, an antagonist of S2-serotonergic receptors, did not improve plethysmographically monitored digital blood flow during controlled cold challenge in 4 women with carefully defined primary Raynaud''s phenomenon. However, ketanserin, if administered at the time of cold induced vasoconstriction, caused prompt vasodilation. These results suggest that serotonin is a contributory element in the maintenance of cold induced vasospasm but that other factors, presumedly adrenergic, initiate the vasoconstrictive response.This publication has 15 references indexed in Scilit:
- Cooling Augments Platelet-Induced Contraction of Peripheral Arteries of the DogExperimental Biology and Medicine, 1984
- The Effects of Platelet-Derived Contractile Agents on Human Digital ArteriesClinical Science, 1984
- Treatment of raynaud's phenomenon with ketanserin, a selective antagonist of the serotonin2 (5‐HT2) receptorArthritis & Rheumatism, 1984
- Role of cold and emotional stress in Raynaud's disease and scleroderma.BMJ, 1983
- Coronary Artery Spasm Induced in Atherosclerotic Miniature SwineScience, 1983
- Inhibitory Role of the Endothelium in the Response of Isolated Coronary Arteries to PlateletsScience, 1983
- Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies.Annals of the Rheumatic Diseases, 1982
- EARLY DETECTION OF SCLERODERMA-SPECTRUM DISORDERS BY INVIVO CAPILLARY MICROSCOPY - A PROSPECTIVE-STUDY OF PATIENTS WITH RAYNAUDS-PHENOMENON1982
- Increased Factor VIII/von Willebrand Factor Antigen and von Willebrand Factor Activity in Scleroderma and in Raynaud's PhenomenonAnnals of Internal Medicine, 1981
- Raynaud's Disease Affecting MenAnnals of Internal Medicine, 1932